Skip to main content

 

Clinical courses

 

Clinical research courses

Role of chromosomal fragile site in the identification and characterization of human malignancy

About Author: Rinki Verma (Research fellow)
Center of Experimental Medicine and Surgery,
Institute of Medical science
Banaras Hindu University
Varanasi - 221005

Abstract:
In 1965 ,  firstly fragility was reported in cells of  a femeal previously irradiated and described  as non-random human chromosome called “ Fragile sites”  are heritable specific chromosome loci that exhibit an increased frequency of gaps, poor staining, constrictions or breaks when chromosomes are exposed to partial DNA replication inhibition. They constitute areas of chromatin that fail to compact during mitosis. They are classified as rare or common depending on their frequency within the population and are further subdivided on the basis of their specific induction chemistry into different groups differentiated as folate sensitive or non-folate sensitive rare fragile sites, and as aphidicolin, bromodeoxyuridine (BrdU) or 5-azacytidine inducible common fragile sites. Most of the known inducers of fragility share in common their potentiality to inhibit the elongation of DNA replication, particularly at fragile site loci. There are seven non-similar folate sensitive (FRA10A, FRA11B, FRA12A, FRA16A, FRAXA, FRAXE and FRAXF) and two non-folate sensitive (FRA10B and FRA16B) and  have been molecularly characterized. Due to dynamic mutation formed DNA repeat sequences and  involving the normally occurring polymorphic CCG/CGG trinucleotide repeats at the folate sensitive and AT-rich minisatellite repeats at the non-folate sensitive fragile sites. These rare fragile site FRAXA is the most important fragile site as it is associated with the fragile X syndrome significant to the clinical side and also explained the predisposition of tumors.

Require Clinical Research Associate in Piramal Healthcare

Piramal Healthcare Limited A major force in the pharmaceuticals and healthcare segment, Piramal Healthcare Limited, incorporating Healthcare Solutions & Pharma Solutions, has an unequivocal vision – to become the most admired pharmaceutical company, with leadership in market share and profits.

Application are invited for the post of Professors, Assistant Professors at Sigma college of Pharmacy

Sigma Institute of Technology and Engineering trust is a registered charitable trust, having registration Number E/6432, and dated 8/1/2004, under public trust Act. The trust registered at Vadodara, has a mission to impart quality education that empowers generation next to build better environment for all. We at the trust follow the footsteps of Sir Sayajirao Gaikwad  in furthering this vision that education reaches all and helps build better tomorrow for all.

PharmaQuiz- 29 | Find answers of PharmaQuiz - 28

ANSWERS of Previous PharmaQUIZ-28:

1.A    2.C    3.A    4.C    5.B

6.B    7.D    8.D    9.A    10.A

Require Freshers for the post of Associate Scientific Manager in Biocon

Biocon is a research-driven, global healthcare company with a strong matrix of capabilities along the biopharmaceutical value chain. Focusing on unmet medical needs in cancer, diabetes and inflammatory diseases, it offers novel therapies on a platform of affordable innovation.
Biocon together with group companies employs more than 2500 employees with approxmimately Rs 1,000 crore turnover and is expected to grow further during the current financial year.

Vacancies in Indian Institute of Technology, Bombay | Require Junior Research Fellow, Research Associate, Post Doctoral Fellow - 3 posts,

IIT Bombay, set up by an Act of Parliament, was established in 1958, at Powai, a northern suburb of Mumbai. Today the Institute is recognised as one of the centres of academic excellence in the country. Over the years, there has been dynamic progress at IIT Bombay in all academic and research activities, and a parallel improvement in facilities and infrastructure, to keep it on par with the best institutions in the world. Institutes in positions of excellence grow with time.

Vacancy for MTech./MD/MVSc./MPharm./MBiotech. or Ph.D in The National Centre for Cell Science as Scientist 'D'

The National Centre for Cell Science (NCCS) took birth as National Tissue Culture Facility in March 11, 1986 with a mandate of basic research, teaching & training, and as a national repository for cell lines/hybridomas etc.  The centre is located in the midst of academically enriched environment of University of Pune campus, Pune.

Need of Approved Chemist : Production & QC (OINTMENT & INJECTABLES) in Radico Remedies

Radico Remedies is premier Pharmaceutical manufacturing company in North India with manufacturing unit in excise free area of Barotiwala ( BADDI) near Pinjore having and GMP, ISO 9001 certifications and WHO compliance, and head office in Delhi.

Work as counselor in Kredent Academy

Kredent Academy is the unique concept where industry professionals have taken the onus of creating a strong knowledge bank in their area of expertise by bridging the gap between theory and practice and by incorporating the practical mode of imparting training.

DESIGN AND IN-VITRO EVALUATION OF MOUTH DISSOLVING TABLETS OF ROSIGLITAZONE MALEATE BY USING NOVEL COPROCESSED SUPERDISINTEGRANTS

About Authors:
S.Pradeep kumar, D.Prathibha, Dr.N.L.Gowrishankar, R.Parthibarajan, L.Matsyagiri
Department of Pharmaceutics, 
Swami Vivekananda Institute of Pharmaceutical Sciences,
Vangapally (V), Yadagirigutta (M), Nalgonda,
Andhra Pradesh, India.

ABSTRACT
The goal of the present investigation was to formulate and evaluate fast dissolving tablets (FDT) of Rosiglitazone maleate. To improve patient compliance, mouth dissolving tablets have emerged as an alternative to conventional dosage forms. Rosiglitazone and Sulfonylurea are given in combination for treatment of type 2Diabetes Mellitus for long term therapy. During this therapy, it is observed that there is uncontrolled increase of blood glucose level, andthe drug undergoes hepatic metabolism. Therefore, mouth dissolving tablets of Rosiglitazone were prepared to overcome this unusual problem and to make use of the inherent advantages of the novel drug delivery system.The tablets were prepared by using direct compression method using Superdisintegrants. Rosiglitazone mouth dissolving tablets containing Cross povidone & Cross carmellose sodium in the ratio 1:1 showed maximum drug release. Formulations were subjected to stability studies. Formulations are stable for 28 days at 40 oC / 75 % RH with insignificant change in the hardness, disintegration time and in vitro drug release pattern.

(adsbygoogle = window.adsbygoogle || []).push({});
GRAND OPENINGS FOR PHARMACISTS @ RUSHRAJ - Govt Posts - 1010 posts

Established under the Act Of State Government- “The Rajasthan University Of Health Sciences Act, 2005” (Act No. 1 of 2005)”on 25 day February, 2005, the University aims to disseminate and advance knowledge in medical and health sciences. The University provides academic and research facilities in various streams to the students studying in various Government Colleges (Medical, Dental, Nursing, Pharmacy & Paramedical) and private colleges/institutions affiliated to this University.

Gall Bladder Cancer as a “Silent Killer”

About Author: Rinki Verma (Research fellow)
Institute of Medical science (CEMS)
Banaras Hindu University
Varanasi - 221005

Abstract:
Gallbladder cancer is a comparatively rare cancer and has poor outcome due to their anatomy and location. It has peculiar geographical distribution being common in central and South America, central and eastern Europe, Japan and northern India; it is also common in certain ethnic groups e.g. Native American Indians and Hispanics (Kapoor VK, McMichael AJ ,2003. It is fifteen uncommon cancers in the world with high mortality rate. The diagnosis is made very late due to its silent course. The majority of patients have advanced disease at the time of presentation which carries a poor prognosis. The modes of spread of gall bladder carcinoma are direct, lymphatic, vascular, neural, intraperitoneal and intraductal. Ultra Sound, CT and MRI are helpful in diagnosis and staging of the disease. Surgery remains the mainstay of treatment and chemotherapy has a very limited role.

Terminalia arjuna: Phytochemistry, pharmacognosy and pharmacological studies

About Author:
Amol.A.Dambal,
Department of Pharmacognosy and Phytochemistry
Govt. College of pharmacy, Kathora naka,
Amravati-444604. (M.S.), INDIA.

ABSTRACT:
The herbal remedies have been employed in various medical systems for the treatment and management of different diseases. The plant Terminalia arjuna has been used in different system of traditional medication for the treatment of diseases and ailments of human beings. The plants contain Arjunilic acid, Triterpine glycosides like Arjunetosides I, II, III, IV, Arjunine and Arjunetein. The bark is rich in Saponnins, natural anti-oxidants (flavonoids-arjunone,arjunolone,leteilin), gallic acid, ellagic acid , phytosterols, rich in minerals like ca,  mg, zn and co, reducing sugars & coloring matter. It has been reported as Cardio tonic, Hepato-protective, Immunomodulatory, Antihyperglycemic, Antihyperlipidemic, Analgesic and Anti-Inflammatory, Antibacterial and Antiulcer properties.The current study is therefore carried out to provide requisite phytochemical and Pharmacological detail about the plant. The plant is cultivated in different parts of India on a small scale at present However; systematic information on different aspects of this species is not available. In this review, an attempt has been made to present this information.

A Review on -A Rare Disorder of Waldenstrom’s Macroglobulinemia

About Authors:
Ms. Shilpa G. Lodha1,  Vanita Nimje2, Ramzan Virani3

1 Department of Biotechnology,
Agnihotri College of Science, Ram Nagar,
Wardha 442001, India.
2 Department of Biotechnology,
Jankievi Bajaj college, Arvi Naka,
Wardha 442001, India.
3 Department of Biology,
Shivramji Moghe College of Science,
Panharkawada- 445 302, India.

Abstract
Many types of Cancer and Malingancy are known, in that Waldenstrom’s macroglobulinemia is rare cancer of an uncommon lymphoproliferative disorder characterized primarily by bone marrow infiltration and IgM monoclonal gammopathy. It should be considered a distinct clinicopathological entity rather than a clinical syndrome secondary to IgM secretion. The concentration of monoclonal IgM can vary widely in Waldenstrom’s macroglobulinemia and it is not possible to define a concentration that reliably distinguishes it from monoclonal gammopathy of undetermined significance (MGUS).  Besides having lots of diagnosis method, there is no single accepted treatment for Waldenstrom’s macroglobulinemia.  Commonly used treatment includes the monoclonal antibody rituximab, sometimes in combination with chemotherapeutic drugs such as chlorambucil, cyclophosphamide, or vincristine or with thalidomide. We have to find out the successful and low cost methods to cure Waldenstrom’s macroglobulinemia.

PharmaQuiz- 28 | Find answers of PharmaQuiz - 27

ANSWERS of Previous PharmaQUIZ-27:

1.A    2.D    3.A    4.D    5.A

6.B    7.C    8.A    9.B    10.A

Walk in Interview for Fresher Pharmacist in Indian Railways | Vacancies in North East Frontier Railway - 12 posts

ENGAGEMENT OF PARA-MEDICAL STAFF ON CONTRACT BASIS AGAINST VACANCIES EXISTING IN PARA -MEDICAL CATEGORY OF NORTHEAST FRONTIER RAILWAY, MALIGAON & ITS DIVISIONS– THROUGH WALK-IN INTERVIEW.

Prescribing Pattern for the Treatment of Dengue in a Tertiary Care Hospital, Bangalore- India.

About Authors:
AK Hafeez, MA Akheel, A Ashfaque, NK Meera
Dept of Pharmacy Practice,
VIPS,
Bangalore, India

Abstract
Aim
: To study the prescribing pattern for the treatment of Dengue in tertiary care hospital in Bangalore.
Methods: A retrospective study was carried on prescribing pattern of drugs for the treatment of dengue in a tertiary care teaching hospital in Bangalore. This study included hundred patients both male and female in the age group of 1 – 70 years, the prescriptions were analysed for the drug therapy given.
Results:The results show that the most commonly prescribed class of drugs were antipyretic (99%), anti-ulcer (95%), antibiotics (69%) and anti emetic (40%). In addition, supplementary treatment was also observed. 100% of suffered population was treated with IV fluids. Since a specific treatment is not available for Dengue, the patients were treated symptomatically.
Conclusion:This survey highlights the demands for a more specific treatment, lest it leads to another epidemic break in the country.

TROUBLESHOOTING IN HIGH PERFORMANCE LIQUID CHROMATOGRAPHY

About Authors:
Ipshita Chattopadhyaya, Ekta Malhotra
Department of Pharmacy,
Jaipur National University,
Jaipur, India

ABSTRACT
(1)The developments in column packing technology and suitable equipment paved the way for what is now called High Performance or High Pressure Liquid Chromatography (HPLC). The new technique provided much higher resolution, more accurate quantitative results, as well as shorter analysis times in comparison to the earlier techniques .During the sixties, new theoretical insights accompanied by important. Since its introduction, HPLC has evolved into an indispensable tool in many analytical laboratories and is applied to diverse analytical problems. Actually, HPLC refers to a number of separation techniques that use a liquid mobile phase, or eluent. Troubleshooting HPLC instrumentation and separations require a fundamental understanding of how the instrument functions and how the separation works. (2)This article provides a practical guide to common HPLC problems, along with more in-depth information to help the reader understand the relationships between the observed symptoms and the underlying causes. The practical approach presented here is meant to serve as both a troubleshooting guide and an HPLC learning tool.

(adsbygoogle = window.adsbygoogle || []).push({});
PharmaQuiz- 27 | Find answers of PharmaQuiz - 26

ANSWERS of Previous PharmaQUIZ-26:

1.C    2.D    3.D    4.A    5.D

6.B    7.A    8.C    9.B    10.C

Requirement of Clinical Research Associate in Siro Clinpharm - 4 openings

SIRO Clinpharm is one of the leading Global Clinical Research Organizations (CROs), offering full scope services conducting clinical trials in the Pharmaceutical, Biotechnology and Medical Devices sectors in compliance with International Standards. We are headquartered in India having global presence in USA, Israel and in Europe at Germany, Czech Republic, Greece, Estonia, Romania, Spain and France.

Subscribe to